News Roche keeps Rituxan evergreen with Breakthrough designation,... Roche is finding new ways to keep its oncology and rheumatoid arthritis blockbuster Ri
News Mylan expects first US Herceptin biosimilar launch Deal with Roche paves way for near-copy of breast cancer blockbuster
News Brexit could deny children access to cancer drug trials Experts call for shake-up of EU regulation.
News Roche breast cancer trial success could kill Puma's rival Perjeta trial success sends rival biotech's share price crashing.
News Patient death raises concerns over Roche haemophilia drug Concerns following event on HAVEN1 trial.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.